Intriguing that the $7 forecast is now out the window unless a buyout is announced. Some talk about the verinata test being inferior, not sure if that is false positive or what, but lower price tends to dictate with the payers. Can sqnm or will sqnm pursue the injunction now that deeper pockets can fight it.